The "List" *** involves 16 items. The "medical community" summarizes the items targeting medical institutions and personnel within the institutions into the following five points: 1. Insurance fraud, which is the first to bear the brunt. The first item of the "List" involves insurance fraud by medical institutions.

Behavioral penalties and inspections will be stepped up this year.

Penalties will be imposed on medical insurance agencies, medical institutions, pharmaceutical business units and other medical insurance service institutions that use fraud, forged certification materials or other means to defraud medical insurance and maternity insurance fund expenditures.

Both the Social Insurance Law and the Basic Medical and Health Promotion Law have express provisions.

The social insurance administrative department will order the person (institution) involved to return the fraudulently obtained social insurance funds and impose a fine of not less than two times but not more than five times the fraudulent amount; the medical insurance administrative department of the people's government at or above the county level shall comply with the relevant laws and administrative regulations on social insurance.

Administrative penalties will be imposed on the parties (institutions) involved.

2. Credit records of medical institutions and personnel are included in the national credit reporting platform. The following item is closely related to all medical institutions and personnel. Once illegal records are included in the credit reporting system, it may have an impact on all aspects of life.

Establish a credit record system for medical and health institutions and personnel, incorporate it into the national credit information sharing platform, and implement joint punishments in accordance with national regulations.

Article 93 of the "Basic Medical Care and Health Promotion Law" states that the health authorities and medical security authorities of people's governments at or above the county level should establish a credit record system for medical and health institutions, personnel, etc., and include it in the national credit information sharing system.

platform and implement joint punishments in accordance with national regulations.

3. Public medical institutions: Articles 6 and 8 of the "List" for supervising centralized procurement are targeted at public medical institutions. These two items are - compliance with the centralized procurement of high-value medical consumables by public medical institutions.

Supervision and inspection of the compliance of centralized drug procurement by public medical institutions.

The law enforcement basis for these two measures comes from the "Regulations on the Functional Configuration, Internal Organizations and Staffing of the National Medical Security Administration", which clarifies that the National Medical Security Administration formulates bidding and procurement policies for drugs and medical consumables and supervises their implementation, and guides the bidding of drugs and medical consumables.

Procurement platform construction.

4. Designated medical institutions and their personnel Articles 7 and 11 of the "List" put forward requirements for designated medical institutions and their personnel.

Article 7: Supervision and inspection of price violations included in the scope of medical insurance.

The law enforcement category of this item not only includes administrative inspections, but also administrative penalties, which means that if you violate laws and regulations, you will be convicted and sentenced.

Article 33 of the Price Law of the People's Republic of China: The price authorities of the people's governments at or above the county level shall supervise and inspect price activities in accordance with the law, and impose administrative penalties on price violations in accordance with the provisions of this law.

Article 11: Strengthen supervision and management of medical services and medical expenses included in the payment scope of the basic medical insurance fund.

According to Article 87 of the Basic Medical Hygiene and Health Promotion Law: The medical security competent authorities of the people's governments at or above the county level shall improve their medical security supervision capabilities and levels, and strengthen the supervision of medical services and medical expenses that are included in the payment scope of the basic medical insurance fund.

Supervise and manage to ensure that basic medical insurance funds are used rationally and are safe and controllable.

5. Provide the actual purchase and sale price and quantity of drugs. Article 15 of the "List": Drug marketing authorization holders, drug manufacturers, drug operating companies and medical institutions shall provide the actual purchase and sale price and purchase and sale quantity of their drugs to the drug pricing authority.

Supervision and inspection of other materials.

Legal Basis Article 86 of the Drug Administration Law of the People's Republic of China: Drug marketing authorization holders, drug manufacturers, drug operating companies and medical institutions shall provide the actual purchase and sale prices of their drugs to the drug pricing authorities in accordance with the law.

and purchase and sales quantities and other information.

Article 33 of the "Price Law of the People's Republic of China" The price authorities of the people's governments at or above the county level shall supervise and inspect price activities in accordance with the law, and implement administrative penalties for price violations in accordance with the provisions of this law.

Article 18 of the Price Law of the People's Republic of China on the prices of the following commodities and services, the government may implement government-guided prices or government fixed prices when necessary: ??(1) A very small number of commodities that are closely related to the development of the national economy and people's lives

Prices; (2) Prices of a few commodities with scarce resources; (3) Prices of commodities operated by natural monopolies; (4) Prices of important public utilities; (5) Prices of important public welfare services.